Towards closing the gap in access to child-friendly formulations of essential medicines

Overview

Over four years, under the framework of GAP-f, WHO comprehensively reviewed formulations of medicines listed on the EMLc to inform the 2023 and 2025 updates of the EMLc. This publication documents the outcomes project including additions, removals and other modifications – all of which were adopted and reflected in the 2023 and 2025 editions of the list. This foundational work ensures that the EMLc remains the most up-to-date global reference for countries and procurement agencies, supporting the alignment of internationally and nationally procured formulations with the latest available options for children.